GLP-1 Weight LossOzempic and other weight-loss jabs linked to nail changes
Research presented in Austria found more nail and scalp complaints among weight-loss jab users, but does not establish that the medicines caused them.
GLP-1 Weight Loss
Reporting on Wegovy, Mounjaro, Ozempic and the new generation of GLP-1 weight-loss medicines: the evidence, the side effects and the patients.
GLP-1 Weight Loss
GLP-1 Weight LossWegovy pill linked to further weight loss after switch from jabs
A study of 194 adults found further weight loss after switching to oral semaglutide, but cannot establish whether changing treatment improved their results.
GLP-1 Weight LossWHO advises against weight-loss injections for under-10s
Global guidance recommends diet and physical activity rather than obesity medicines for under-10s, while leaving room for clinical trials.